2022 Wanamaker’s November Sale Catalog Released – Horse Racing News


The 2022 Wanamaker’s November Sale catalog is now available at wanamakers.com. The sale has drawn twenty-four entries, with horses of racing age, in-foal broodmares, racing/broodmare prospects, yearlings, and weanlings on offer.

Bidding will open on Thursday, Nov. 24 at 8 a.m. ET, with the first listing set to close at 5 p.m. ET. Subsequent listings will close in three-minute increments. Detailed information on the buying process can be found at wanamakers.com/buy.

Housatonic Bloodstock has consigned seven horses for this month’s auction. This includes two mares in foal: Best Moon Ever, a 4-year-old daughter of Malibu Moon carrying a foal by top Mid-Atlantic stallion Weigelia, and Rockport Dancer, a daughter of Rockport Harbor carrying a foal by the graded stakes winning juvenile Instagrand. Also on offer from this consignment are four mares that are not currently pregnant, as well as a well-built yearling colt by Dominus.

Other highlights include a certified New York-bred weanling colt by top New York stallion, War Dancer. He is out of a winning mare who is also a half-sister to the stakes-winning, six-figure earning mare, Say Toba Sandy. Also offered is Mongolian Humor, a seven-year-old broodmare prospect who earned upwards of $230,000 across 39 career starts and hails from a family filled with black type.

For more information on those being offered in the 2022 Wanamaker’s November Sale, see wanamakers.com. Prospective buyers may browse the website to view pedigrees, pictures, and videos of each hip offered. In-person inspections may be scheduled by contacting sellers with the information provided in the catalog.

Entries are still open for the second annual Wanamaker’s Pennsylvania-Bred Sale, held in conjunction with the Pennsylvania Horse Breeders Association. Entries close on Nov. 29, the catalog will be released on Nov. 30, and bidding will close on Dec. 8. The entry fee for the Pennsylvania-Bred Sale will be discounted to $150 and commission will remain at 5 percent. There are no commissions on RNAs through Wanamaker’s.